Research Strategy Committee
They advise us on the development and implementation of our research strategy.
The committee also reviews our research priorities for MS and scrutinises our funding programme, including how we decide what to fund.
The RSC meets three times a year and:
- oversees, guides and monitors the development and implementation of our research strategy.
- reviews our research priorities on an annual basis and advises how these can best be incorporated into our funding decisions.
- advises how we can commission research to support our strategy and priorities.
- advises and assists us to influence other research funders to support our strategy.
- provides recommendations on funding for strategically important collaborative projects.
- approves the appointment of chairs to our research panels.
Because of these responsibilities, the RSC is independent of our research applicants and grant holders. Members are not allowed to apply to us for research funding during their tenure.
Our Board of Trustees decides the structure of the committee. It always includes at least three people with MS from our Research Network. All our members are appointed for a term of three years, for a maximum of two terms.
- Professor Nigel Leigh, Brighton and Sussex Medical School
- Stuart Nixon MBE, Research Network Member
- Nigel Leigh (Co-chair)
- Stuart Nixon (Co-Chair)
- Rachel Allen
- Olga Ciccarelli
- Susan Crane (Trustee)
- Gabriele De Luca
- Denise Fitzgerald
- Christine Gibbons (Trustee)
- Tanja Kuhlmann
- Sasha Leigh
- Patrick Lewis
- Michael O’Sullivan
- Waqar Rashid
The RSC was created in 2010 to help us implement recommendations around the management of our research programme. And to ensure our research programme remains aligned to our research strategy.
When it was created, our research strategy, Putting the Pieces Together To Beat MS, was due to end in 2012. Afterwards the RSC oversaw the development of our new research strategy 2013-2017, Together to Beat MS.
Our current research strategy will run from 2018 to 2022.